Trial site
Istituto Mediterraneo Per I Trapianti E Terapie Ad Alta Specializzazione S.r.l. I.S.M.E.T.T. S.r.l.
- 12running trials
- 7closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- High blood pressure10 trials
- Pulmonary arterial hypertension10 trials
- Idiopathic pulmonary fibrosis4 trials
- Fatty liver disease (MASLD/MASH)3 trials
- Liver cirrhosis2 trials
- Lung cancer1 trial
- Type 1 diabetes1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 38 trials
- Phase 27 trials
- Phase 1/23 trials
- Phase 2/31 trial
- Status
- Completed7 trials
- Active, not recruiting6 trials
- Not yet recruiting4 trials
- Recruiting2 trials
- Lead sponsor
- Aerovate Therapeutics Inc.2 trials
- Insmed Incorporated2 trials
- United Therapeutics2 trials
- Agomab Spain S.L.U.1 trial
- AllRock Bio, Inc.1 trial
- and 11 more
Running trials
Not yet recruiting
Not yet recruiting
A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes
Active, not recruiting
Active, not recruiting
Enrolling by invitation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure3 recruiting
- Pulmonary arterial hypertension3 recruiting
- Idiopathic pulmonary fibrosis2 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Liver cirrhosis1 recruiting
Closed trials
Completed
Active, not recruiting
MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Completed
Completed
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 14 Nov 2026